Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?

Area of Science:

• Hematology
• Molecular Biology
• Biotechnology

Background:

• Detecting small leukemic clones is crucial for managing acute leukemias and myeloproliferative disorders.
• Measurable residual disease (MRD) monitoring requires highly sensitive detection methods.

Purpose of the Study:

• To review the application and advantages of digital PCR (dPCR) for detecting leukemic clones.
• To summarize current data on dPCR use in acute myeloid leukemia and myeloproliferative disorders.

Main Methods:

• Digital PCR (dPCR) for absolute nucleic acid quantification.
• Review of published studies on dPCR in hematologic malignancies.

Main Results:

• dPCR provides high precision, reliable absolute quantification, and excellent reproducibility.
• dPCR is effective for detecting low amounts of target DNA, suitable for MRD detection.

Conclusions:

• dPCR is a promising technology for sensitive MRD detection in acute leukemias and myeloproliferative disorders.
• Current limitations include higher costs, lack of standardized methods, and limited laboratory accessibility.